Accessibility Tools

Clinical Guidelines & Pathways


Ulcerative Colitis (Moderate to Severe) – Treatment Pathway AFTER failure of conventional therapy


Specialist Use only

Updated Dec 2023 (Mirikizumab added)
Updated July 2023 Dose escalation info added
Updated Jan 2023 (upadacitinib added)
Updated Dec 2022 (ozanimod added)

View Document

Guideline Categories: Gastroenterology

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: biologic treatment, colitis, jak inhibitor, ulcerative

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net